key: cord-1056460-2b43rm3p
authors: Sun, Yangbai; Zhou, Renpeng; Zhang, Hao; Rong, Liu; Zhou, Wang; Liang, Yimin; Li, Qingfeng
title: Skin is a potential host of SARS-CoV-2: a clinical, single-cell transcriptome-profiling and histological study.
date: 2020-08-19
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.08.057
sha: b36109ac7744669bfd730fb31d8cd4823bff2817
doc_id: 1056460
cord_uid: 2b43rm3p

nan

The 2019 novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The lung is the main target organ of SARS-CoV-2, however, extra-pulmonary virus distribution [1] has been observed. Recently, skin manifestations including skin rashes, morbilliform exanthema and chilblains [2] [3] [4] have been reported as possible presentations in COVID-19 patients. However, the number of such cases has been relatively small and whether SARS-CoV-2 might infect injured skin and cause COVID-19 is still unknown. Therefore, we aimed to examine whether the skin is a potential host of SARS-CoV-2 by analyzing clinical, histological and single-cell transcriptome data. Table 1 ). The majority of skin rashes were urticarial (52% of 52 cases), followed by papule (15%), erythema and papule (14%), scratch (10%), rahagades (6%) and chilblains (4%).

Among the 52 patients with skin rashes, 21 patients were treated with corticosteroid (prednisone, 10 mg tid, po), and the average time for skin rash recovery was 4.2±2.3

days. This was significantly shorter than 8.3±5.1 days in patients who were not treated with corticosteroid (Supplemental Table 2 ). Although the use of corticosteroids in treatment of patients with COVID-19 remains controversial [5] , our J o u r n a l P r e -p r o o f data suggested that skin lesions are associated with COVID-19 and that corticosteroid therapy is effective.

To further investigate the association of SARS-CoV-2 and skin rashes present in COVID-19 patients, we performed single-cell rna-seq (scRNA-seq) with keratinocytes from normal human skin. The data showed that angiotensin-converting enzyme2 (ACE2), the viral host cellular receptor, was highly and specifically expressed in the granulosum of the skin while transmembrane serine proteases (TMPRSSs) were relatively scattered in all keratinocytes, melanocytes, duct, Schwann and neurocyte cells. The co-expression of ACE2 and TMPRSSs was particularly found in the granulosum (Fig 1B) . Nucleocapsid protein(NP) was expressed in cytoplasm of epidermis from COVID-19 patients but was not detected in normal skin tissue (Fig 1C) .

These data suggested that the skin is a potential host of SARS-CoV-2. Although this hypothesis needs further study, it is intriguing to conjecture that SARS-CoV-2 may directly infect the keratinocytes in the injured skin (Fig2).

In summary we noted in 52 patients with COVID-19, that skin manifestation can be present before the onset of fever or co-exist with fever, and that ACE2 and 

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

COVID-19) infection-induced chilblains: A case report with histopathologic findings. JAAD Case Rep

COVID-19 can present with a rash and be mistaken for dengue

Morbilliform Exanthem Associated with COVID-19. JAAD Case Rep

Efficacy and Safety of Corticosteroids in COVID-19 Based on Evidence for COVID-19, Other Coronavirus Infections, Influenza, Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis